Patients struggle with lack of consistent coverage for popular weight-loss drugs
Coverage complications are not unusual in the U.S. health care system. But the challenge is magnified for these obesity ...
ABC News12d
Weight-loss drugs
A study suggests that weight loss medications like Ozempic may help ... Eli Lilly says a new trial showed the key ingredient in its popular drugs Zepbound and Mounjaro helped slash the chance ...
The Washington Post3d
Weight-loss drugs aren’t just slimming waists. They’re shifting the economy.
Ozempic, and its GLP-1 cousins Mounjaro, Wegovy and Zepbound, may not be the lightbulb ... in fitness in this group — 35 percent of weight-loss drug users PwC surveyed said they are exercising ...
Yearslong shortage of popular weight-loss and diabetes drugs resolved, FDA says
Shortages of Ozempic and Wegovy that have been in place for more than two years have been resolved, as supplies of obesity ...
Weight-loss drugs are about to get a lot better
A new generation of anti-obesity drugs aims for greater effectiveness, fewer side effects, and more convenience.
Weight-loss drug Zepbound helped drive Ireland to $76 billion in goods exports to the U.S. last year—a bittersweet reminder of the challenges ahead
Ireland's pharmaceutical industry shipped billions' worth of goods to the U.S., but face threats from Trump 2.0.